Welcome to our dedicated page for Birchtech SEC filings (Ticker: BCHT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Birchtech Corp. (BCHT) SEC filings, offering detailed insight into the company’s financial reporting, capital structure, and material events. Operating in the pollution and treatment controls industry, Birchtech focuses on specialty activated carbon technologies for air and water treatment, and its filings reflect revenue from product, license, equipment, and demonstrations/consulting categories.
Through Birchtech’s registration statements, such as its S‑1, investors can review information on business segments, revenue breakdowns, equity plans, and historical financial statements, including restatement adjustments to accumulated deficit and retained earnings. These documents outline how the company reports income from SEA ae sorbent licensing to coal-fired utilities, product and equipment activities, and consulting or demonstration services.
Current reports on Form 8‑K are particularly important for Birchtech. One 8‑K describes the final judgment entered in favor of the company by the U.S. District Court for the District of Delaware in a patent infringement action, including damages that incorporate pre‑judgment interest. Another 8‑K details the 1‑for‑5 reverse stock split of Birchtech’s common stock, explaining the certificate of amendment filed in Delaware, the effective date, and how outstanding shares and equity-linked securities are adjusted.
On this page, users can also follow quarterly and annual reports (Forms 10‑Q and 10‑K when filed), which typically contain management’s discussion and analysis, segment information, and disclosures relevant to Birchtech’s air and water businesses, intellectual property matters, and capital resources.
Stock Titan enhances these filings with AI-powered summaries that explain key sections, highlight changes from prior periods, and clarify technical language in documents such as 10‑K, 10‑Q, and 8‑K. Real-time updates from EDGAR mean that new filings, including any future registration statements, proxy materials, or Form 4 insider transaction reports, are added as they become available. This allows investors and researchers to quickly understand how legal judgments, reverse splits, equity awards, and revenue trends are reflected in Birchtech’s official SEC disclosures.
Birchtech Corp. filed an initial Form 3 insider report for Mioska Michael David, who serves as Chief Financial Officer. The filing, as provided, does not list any equity holdings or report any buy, sell, or other insider transactions for him.
Birchtech Corp. has appointed experienced finance executive Michael Mioska, CPA, MBA, as Chief Financial Officer. He has over 20 years of accounting, audit and financial reporting experience across the United States and Canada and has consulted for Birchtech since 2023.
Mioska has worked closely with Birchtech’s finance team, giving him deep familiarity with the company’s operations, systems and strategic priorities. Management expects his capital markets, M&A and reporting expertise to support the next phase of growth in Birchtech’s specialty activated carbon air and water treatment businesses.
Birchtech Corp. set the date for its 2026 Annual Meeting of Stockholders for Thursday, July 23, 2026, to be held as a virtual-only meeting conducted via remote communications. The company will provide the exact time, access details, and agenda items in its upcoming proxy statement.
Because no annual meeting was held in 2025, stockholders seeking to include proposals in the 2026 proxy materials under Rule 14a-8 must deliver them to the company’s Corsicana, Texas headquarters by the close of business on May 26, 2026. The same deadline applies to stockholder proposals or director nominations submitted outside Rule 14a-8, all of which must satisfy the advance notice provisions in Birchtech’s amended and restated bylaws.
Birchtech Corp. files its annual report outlining its specialty activated carbon business and the main risks it faces. The company supplies patented SEA® mercury-capture technology to coal-fired power plants and is building a water treatment platform focused on PFAS “forever chemicals.” It is investing in two Design Centers to develop reactivated granular activated carbon and ion exchange resins and plans a regional thermal reactivation facility. Birchtech reports a concentrated customer and supplier base, ongoing patent litigation and inter partes review activity, significant reliance on U.S. environmental rules such as MATS and PFAS standards, a 1-for-5 reverse stock split, and recent uplisting of its common stock to the NYSE American.
Birchtech Corp. expanded its recent stock sale through a partial use of the underwriters’ over-allotment option. The company originally sold 6,250,000 common shares at $2.40 per share, generating gross proceeds of $15.0 million.
On March 17, 2026, the underwriters bought an additional 600,000 shares at the same price, adding approximately $1.4 million of gross proceeds. In total, 6,850,000 shares have been issued in the offering, with aggregate gross proceeds of about $16.4 million and 337,500 over-allotment shares still available.
Birchtech Corp. President and CEO Richard MacPherson reported an open-market purchase of the company’s common stock. He bought 312,500 shares at $2.40 per share for a total of $750,000 in a public offering of 6,250,000 shares that closed on February 27, 2026.
Following this transaction, his directly owned stake increased to 2,955,095 common shares. The share amounts in the filing reflect Birchtech’s 1-for-5 reverse stock split that became effective on December 26, 2025.
Birchtech Corp. completed an underwritten public offering of 6,250,000 shares of common stock at $2.40 per share, generating approximately $13.1 million in net proceeds. Underwriters also have a 30‑day option to buy up to 937,500 additional shares, which would lift net proceeds to about $15.2 million if fully exercised.
The company plans to use the cash, together with existing funds, for ongoing operating expenses, working capital and other general corporate purposes. Birchtech’s CEO purchased $750,000 of stock in the deal, or 312,500 shares, and directors and executive officers agreed to a 90‑day lock‑up. The offering supports Birchtech’s uplisting, as its common stock was approved for trading on the NYSE American under the symbol BCHT while remaining listed on the Toronto Stock Exchange.
Birchtech Corp. is offering 6,250,000 shares of common stock in a primary offering at $2.40 per share. The offering is expected to produce proceeds to the company of $13,950,000 before expenses, with a 30-day underwriter option for an additional 937,500 shares. The company reports 19,455,966 shares outstanding prior to the offering and 25,705,966 shares outstanding immediately after the offering (assuming no exercise of the option). The prospectus gives effect to a 1-for-5 reverse stock split effective December 26, 2025 and notes expected NYSE American trading under the symbol BCHT beginning February 26, 2026. The Chief Executive Officer intends to purchase $750,000 (an aggregate of 312,500 shares) in the offering.